Zycus to Host Horizon 2024, the Premier Conference for Procurement Innovation on May 15-17
Zycus, the pioneer in Generative AI-powered Source-to- Pay solutions, announces Horizon 2024, its annual conference dedicated to the future of procurement technology. It will take place from May 15 - 17, 2024, at the St. Regis Bal Harbour Resort in Miami, Florida.
"Horizon is crafted to offer a unique event experience that goes beyond typical conferences, fostering two-way dialogues over one-way presentations. Forget what you know about procurement. Horizon 2024 will challenge your assumptions and equip you with the tools to reimagine the future of your business," says Aatish Dedhia, Founder & CEO of Zycus.
This exclusive, invite-only conference will gather over 200 delegates for three days of intensive learning and networking. It will feature over 20 expert-led sessions, strategic workshops, and panel discussions, focusing on actionable insights and advanced GenAI strategies. Attendees will enjoy a blend of professional enrichment and unique social experiences, from icebreaking activities on Miami's shores to elegant dinners and a spectacular yacht gala.
Spotlight on Generative AI:
GenAI Prioritization for Procurement: Now or Never
10X Source-to-Pay with GenAI: Time to Level Up
Transformative Case Studies and Panels:
Delta's Procurement Transformation Flight: Building Smarter Teams with GenAI
PwC's Source-to-Pay Plans: Intake to Intelligent Procurement with Gen AI
Innovative Approaches to Procurement:
Broadridge's Blueprint for Business Growth: Evolution, Evaluation, and Empowerment
The Sustainable Procurement Imperative: Integrating ESG Practices into S2P Transformation
Zycus is the leader in Source-to-Pay (S2P) solutions, pioneering the world's first Generative AI powered platform that helps procurement achieve 10X speed and efficiency. It has been a trusted partner of choice for large global enterprises and is consistently recognized by leading analysts like Gartner and Forrester for its organically built, composable and extensible source-to-pay suite.
The Phase IIa COURSE trial was a proof-of-concept study in people with moderate to very severe chronic obstructive pulmonary disease (COPD) with a broad range of blood eosinophil counts (BEC) and irrespective of emphysema, chronic bronchitis or...
Endeavor BioMedicines, a clinical-stage biotechnology company developing medicines with the potential to deliver transformational clinical benefits to patients with life-threatening diseases, announced results from a completed Phase 2a clinical trial...
Savara Inc. (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, presented a poster at the American Thoracic Society (ATS) 2024 International Conference that is taking place May 17-22, 2024, in San Diego,...
Orion Health, a global leader in digital health solutions, announced today that it has been awarded partner status by Panda Health for its Orchestral Health Intelligence Platform, one of three pillars of the Unified Healthcare Platform.
Panda Health...
eWTP Arabia Capital Technology Fund I ("Techology Fund I"), managed by eWTP Arabia Capital ("eWTPA"), one of the leading private equity firms in the Middle East, was listed in the Preqin League Tables as the the fifth top-performing VC funds in the...
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024).
The campaign focuses on access to IBD care and treatment as the burden of...